Development and Validation of a Stability-Indicating HPTLC Method for Analysis of Rasagiline Mesylate in the Bulk Drug and Tablet Dosage Form

Figure 5

Densitogram of base (5 N NaOH, reflux for 3 h, temp 80°C) treated rasagiline mesylate; peak 1 (degraded—𝑅_𝑓=0.26), peak 2 (degraded—𝑅_𝑓=0.52), peak 3, (degraded—𝑅_𝑓=0.67), and peak 4 (rasagiline mesylate—𝑅_𝑓=0.76).